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Identifying characteristics of HIV-infected adults likely to have poor treatment outcomes can
be useful for targeting interventions efficiently. Research in economics and psychology sug-
gests that individuals’ intertemporal time preferences, which indicate the extent to which
they trade-off immediate vs. future cost and benefits, can influence various health behav-
iors. While there is empirical support for the association between time preferences and vari-
ous non-HIV health behaviors and outcomes, the extent to which time preferences predict
outcomes of those receiving antiretroviral therapy (ART) has not been examined
previously.
Methods
HIV-infected adults initiating ART were enrolled at a health facility in Kenya. Participants’
time preferences were measured at enrollment and used to classify them as having either a
low or high discount rate for future benefits. At 48 weeks, we assessed mortality and ART
adherence, as measured by Medication Event Monitoring System (MEMS). Logistic regres-
sion models adjusting for socio-economic characteristics and risk factors were used to
determine the association between time preferences and mortality as well as MEMS adher-
ence90%.
Results
Overall, 44% (96/220) of participants were classified as having high discount rates. Partici-
pants with high discount rates had significantly higher 48-week mortality than participants
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with low discount rates (9.3% vs. 3.1%; adjusted odds ratio 3.84; 95% CI 1.03, 14.50).
MEMS adherence90% was similar for participants with high vs. low discount rates
(42.3% vs. 49.6%, AOR 0.70; 95% CI 0.40, 1.25).
Conclusion
High discount rates were associated with significantly higher risk of mortality among HIV-
infected patients initiating ART. Greater use of time preference measures may improve
identification of patients at risk of poor clinical outcomes. More research is needed to further
identify mechanisms of action and also to build upon and test the generalizability of this
finding.
Introduction
Despite the significant health improvements achieved as a result of the successful scale-up of
antiretroviral therapy (ART) in sub-Saharan Africa, mortality rates have been high among
HIV-infected adults receiving ART, particularly in the first year of treatment [1–3]. While
early mortality has partly been the result of ART initiation at low CD4+ T-cell counts [1, 2],
studies have also identified individual and health system factors affecting mortality [2] as well
as adherence and retention in care [4–6]. Research in economics and psychology highlights
other potentially important individual-level predictors of health behavior, and there has
recently been heightened interest in utilizing insights from these disciplines to interpret and
influence behaviors related to HIV prevention and treatment. An important in models of deci-
sion-making has been individuals’ intertemporal time preferences, which indicate how they
weigh immediate vs. future costs and benefits. By describing the extent to which an individual
discounts delayed outcomes, time preferences have been hypothesized to be an important pre-
dictor of health behaviors that have immediate costs (or benefits) but delayed rewards (or
costs) [7]. Across many studies of non-HIV related health behaviors, individuals’ time prefer-
ences have predicted health behaviors with immediate costs and delayed benefits, such as
smoking [8–10], alcohol use [11–13], obesity [14], hypertension management [15], adherence
to asthma-control medication [16], and sexual risk behavior [17]. However, some studies have
found no relationship between time preferences and health behaviors such as vaccination [18,
19]. However, the extent to which time preferences predict outcomes of those receiving ART
has not been examined previously.
Adherence to ART and retention in care require incurring present and immediate costs
(e.g., time and travels costs to seek care, adverse side effects, and inconvenience of taking daily
medication) in order to realize future benefits (e.g., living longer, being able to work, and being
less likely to infect sexual partners with HIV) [4, 6]. Thus, it is plausible that outcomes of indi-
viduals receiving ART would be worse for those who display higher discounting of delayed out-
comes. However, time preferences are rarely measured in patient encounter forms or studies
that focus on outcomes of those on ART. Examining the association between patients’ time
preferences and outcomes such as adherence and mortality can suggest novel ways of identify-
ing patients needing outreach and support following ART initiation, thereby leading to
improvements in clinical outcomes and program cost-effectiveness.
This study examined whether the time preferences of HIV-infected adults receiving ART
are associated with mortality and ART adherence over a 48-week period.
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Methods
Participants
Data were collected within a randomized controlled trial (RCT) that tested whether mobile
phone text messages improved ART adherence (ClinicalTrials.gov identifier NCT01058694)
[20]. The study site was a government-run health facility in Kenya’s Nyanza region where the
USAID-Academic Model Providing Access to Healthcare (AMPATH) provided free compre-
hensive care to HIV-infected patients. Patients who were aged>18 years, HIV-infected, and
were either initiating ART at the time of enrollment or had initiated ART within the past 3
months were eligible to participate in the RCT. There were no other eligibility criteria for the
RCT. Patients who met eligibility criteria and provided informed consent were provided with a
mobile phone and randomized to receive different types of daily or weekly text messages that
encouraged ART adherence or to a control group that received no text messages. This study
focused on the control group in the RCT, which did not receive the text message interventions.
Study participants were enrolled between June 2007 and August 2008.
Procedures
The RCT procedures have been described in greater detail previously [20]. At the time of
enrollment, participants completed a survey that assessed demographic characteristics and
time preferences (described below). Study staff at the clinic’s pharmacy transferred one of their
three antiretroviral medications to a pill bottle equipped with a Medication Event Monitoring
System (MEMS) cap (Aardex Group, Switzerland) that electronically recorded the date and
time of each opening. Participants were expected to return to the clinic each month per stan-
dard clinic protocol, and study staff downloaded MEMS data at each return visit. Participants
were followed for 48 weeks after enrollment. The Institutional Research Ethics Committee of
the Moi University School of Medicine and the Institutional Review Boards of Georgetown
University and the University of North Carolina at Chapel Hill approved the study. The study
used informed consent forms and procedures that were approved by the ethics committees. All
participants provided written informed consent to participate in the study. Signed consent
forms were retained by the research assistants who obtained informed consent and then stored
in secure facilities. Participants were also provided with a copy of the signed consent forms.
Measures
Outcomes. The main outcome for this secondary analysis was mortality at 48 weeks after
enrollment. Information on mortality was obtained by study staff based on a review of clinic
records. ART adherence was calculated as the number of MEMS-recorded bottle openings
divided by the number of prescribed doses until MEMS data were unavailable due to mortality
or loss to follow-up. The number of daily bottle openings was limited to two in order to avoid
overstating adherence due to extraneous bottle openings. We then defined a binary indicator of
adherence90% during the study period.
Time preferences. Participants were asked to choose between hypothetical monetary pay-
ments made to them either on the day of the interview or in one year, a standard method of
eliciting intertemporal time preferences. Participants were asked to suppose they had just won
a prize that will give them a series of payments over time and asked whether they would choose
to receive 550 Kenya Shillings (about US$7.00) immediately or 1,000 Kenya Shillings (US
$12.50) in one year. Participants indicating they would choose the immediate reward were clas-
sified as having a high discount rate (i.e., displaying more impatience and less future
Time Preferences and HIV Treatment Outcomes
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connectedness), while those indicating they would choose the delayed reward were classified as
having a low discount rate (i.e. less impatience and more future connectedness).
Statistical analyses
We used logistic regression analyses to examine the association between participants’ time
preferences and mortality as well as adherence. In the unadjusted model, the two outcome vari-
ables were regressed on the binary indicator of whether a participant had a high discount rate.
In the adjusted model, participants’ age, sex, education, marital status, household size, travel
time to clinic, wealth (measured by indicator of house with iron roof), alcohol use, and an indi-
cator of whether participants reported feeling tired or lacking energy in the past week (a mea-
sure of health status at the time of ART initiation) were also included as covariates. All analyses
were conducted with STATA version 13.1.
Results
Among 231 participants in the control group of the RCT, 11 were excluded from the analyses
due to missing data on time preferences and other variables included in the model. For the
remaining 220 participants, over two thirds were female and the average age was 36.1 years
(Table 1). The average travel time to the ART clinic was 1.5 hours. About half the participants
reported feeling tired or lacking energy in the past week. Nearly one-half of participants had
high discount rates (43.6%, 96/220).
At 48 weeks, 5.9% (13/220) participants were deceased. There was a sizable difference in
mortality between participants with low and high discount rates (3.1% and 9.3%, respectively).
In regression analysis that included adjustment for covariates (Table 2), participants with high
Table 1. Participant characteristics and outcomes.
Time preferences
All participants Low discount rate High discount rate P-value
N 220 124 96
Participant characteristics
Age, in years (mean) 36.1 36.3 35.7 0.65
Female 68.6% 65.1% 73.2% 0.20
Married or cohabitating 45.6% 47.3% 43.3% 0.55
Widowed 38.1% 36.4% 40.2% 0.57
Household size 6.5 6.4 6.6 0.66
Completed primary school 56.6% 52.7% 61.9% 0.17
House has iron roof 84.5% 82.2% 87.6% 0.26
Travel time to clinic, in hours (mean) 1.5 1.5 1.4 0.78
Tired or lacking energy in past week 51.7% 47.6% 57.3% 0.15
Sometimes drinks alcohol 8.0% 8.5% 7.2% 0.72
Outcomes
MEMS adherence 90% over 48 weeks 45.9% 49.6% 42.3% 0.28
Deceased at 48 weeks 5.9% 3.1% 9.3% 0.05
Notes: P-values are from chi-squared tests comparing characteristics of participants with low and high discount rates (t-tests for continuous variables).
Participants were classiﬁed as having a low or high discount rate discount rate based on their choice between hypothetical monetary payments made
either on the day of the interview or in one year, a standard method of eliciting intertemporal time preferences. Abbreviations: MEMS, medication event
monitoring system.
doi:10.1371/journal.pone.0145245.t001
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discount rates were significantly more likely to be deceased at 48 weeks than those with low dis-
count rates (adjusted odds ratio (AOR) 3.84; 95% CI 1.03, 14.50).
Nearly half (45.9%, 101/220) the participants achieved MEMS adherence90% during the
48-week study period. MEMS adherence90% was achieved by 42.3% of participants with a
high discount rate and 49.6% of participants with a low discount rate. However, participants’
discount rates were not associated with MEMS adherence in the regression analysis (AOR 0.70;
95% CI 0.40–1.25).
Participants with low discount rates did appear to have better health status at the time of
ART initiation than those with high discount rates (47.3% reporting feeling tired or lacking
energy compared to 57.3%). This baseline measure of health status and other covariates
included in the regression model had the expected direction of associations with mortality and
adherence, but the associations were generally not statistically significant.
Discussion
A simple measure of HIV-infected adults’ time preferences obtained near the time of ART ini-
tiation was used to classify participants as having either low or high discount rates. Participants
with high discount rates had significantly higher 48-week mortality, an association that has not
been documented previously in the literature on HIV treatment outcomes. These patients also
had lower ART adherence but the association was not statistically significant. Despite the small
sample size in this study, the findings suggest that measuring patients’ time preferences at the
time of ART initiation may be useful for identifying those who are particularly in need of clini-
cal support and monitoring. Further measurement and analysis of time preferences among
larger populations of patients receiving ART, with the inclusion of additional measures of
Table 2. Association between time preferences, mortality, and MEMS adherence.
Deceased at 48 weeks MEMS Adherence 90%
Odds ratio (95% CI) Odds ratio (95% CI)
High discount rate 3.19 (1.02–10.70) 3.84 (1.03–14.50) 0.74 (0.44–1.26) 0.70 (0.40–1.25)
Age
18–24 - Reference
25–34 0.90 (0.14–5.86) 1.48 (0.55–4.00)
35–44 1.28 (0.17–9.61) 2.16 (0.76–6.13)
45 and above 0.92 (0.09–9.37) 1.79 (0.58–5.51)
Female 0.21 (0.04–1.06) 1.64 (0.75–3.59)
Married or cohabitating 0.21 (0.04–1.28) 1.54 (0.61–3.88)
Widowed 0.19 (0.03–1.41) 1.17 (0.46–2.98)
Household size 1.07 (0.84–1.37) 1.09 (0.96–1.23)
Completed primary school 0.97 (0.25–3.74) 0.72 (0.39–1.33)
House has iron roof 0.94 (0.16–5.33) 1.75 (0.75–4.06)
Travel time to clinic (hours) 1.14 (0.69–1.86) 0.89 (0.68–1.16)
Tired or lacking energy in past week 2.42 (0.61–9.59) 1.18 (0.64–2.13)
Sometimes drinks alcohol 0.85 (0.08–9.37) 0.29 (0.07–1.12)
Notes: Results from logistic regression models. Outcome variable in columns (1) and (2) is a binary indicator of mortality of 48 weeks and in columns (3)
and (4) is a binary indicator of 48-week MEMS adherence 90%. The binary variable “high discount rate” indicates whether the participant chose to
receive hypothetical monetary payments on the day of the interview rather than in one year, a standard method of eliciting intertemporal time preferences.
Abbreviations: CI, conﬁdence interval; MEMS, medication event monitoring system.
doi:10.1371/journal.pone.0145245.t002
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clinical outcomes during various stages of treatment, may yield valuable insights on how to tar-
get adherence interventions and which interventions to choose.
The finding that 48-week mortality, which was similar to rates reported in other studies
[21], was significantly higher for those with high discount rates is a striking result that reveals
the potential value of measuring time preferences at the time of ART initiation. This result was
robust to controls for other risk factors that may have been correlated with time preferences,
such as wealth and health status at the time of ART initiation.
Medication adherence is an a priori reason why patients’ time preferences may predict clini-
cal outcomes after ART initiation, since adherence involves incurring short-term costs in order
to achieve long-term health benefits. Interventions that can promote ART adherence vary con-
siderably in cost and complexity [22], resulting in a need for care programs to target interven-
tions selectively. Since time preference measures can be obtained from patients at the time of
ART initiation and are feasible to implement even among individuals with low education, they
may enable programs to allocate more resource-intensive interventions to patients with high
discount rates, much in the way that patients’ reports of substance abuse or depression are
sometimes used to identify support needs. For patients with high discount rates in particular,
the rationale for using financial incentives as an intervention to improve adherence may also
be stronger. Given the growing interest in behavioral economics and in using incentives to pro-
mote adherence and retention in care [23], this study suggests ways to identify patients who
may benefit the most from such interventions.
Paired with the results for mortality, the lack of a significant association between time pref-
erences and adherence is intriguing. Our result that patients with high discount rates have
lower adherence is consistent with the finding of higher mortality for these patients, but the
lack of a significant association may be due to limited statistical power. However, the result
may be consistent with some previous research that time preferences are associated with “hot”
or impulsive behaviors such as drug use and gambling but not with “cold” behaviors such as
medication adherence or vaccination uptake [19]. Thus, other mediators apart from adherence
that were not studied here may better explain why time preferences predict mortality. The
mechanisms explaining the association of time preferences and mortality require further
investigation.
Key strengths of this study include a clinical population in a high prevalence setting, a long
follow-up period, objective adherence measures, and innovative use of a simple time preference
measure to predict outcomes. Importantly, the time preference measure used in this study
resembles measures used in other studies conducted in resource-limited settings and was easy
to implement even among patients with low literacy or numeracy. The results were also robust
to controlling for individuals’ socio-economic status, which can often be associated with time
preference measures. Limitations include the relatively small sample size of patients, which
may have limited statistical power and generalizability. Second, the results may be sensitive to
the particular time preference measures used. While there is no gold standard for measuring
time preferences [24], more detailed measures could classify patients into several categories of
discount rates. The feasibility of using more burdensome measurement strategies in high-vol-
ume clinics may be limited, however. One concern about asking participants to make choices
between hypothetical monetary payments in the present vs. the future is that in a low-income
population, the choices may reflect current economic circumstances rather than discount rates.
While we cannot rule out this possibility and time preference measures can be sensitive to eco-
nomic circumstances, the robustness of the main result to inclusion of controls for wealth sug-
gests that this is not a major source of bias. This study also did not measure whether
participants displayed time-inconsistent (or present-biased) preferences, which have been
hypothesized in the behavioral economics literature as an additional barrier to behaviors
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involving immediate costs and delayed benefits [25, 26]. Implementing additional measures of
time preferences and testing their association with additional clinical outcomes could offer
valuable new insights. Finally, bias stemming from residual confounding remains a possibility
despite our attempts to control for various individual characteristics. Although we did not con-
trol for baseline CD4 counts, which were unavailable in this study, we did include a self-
reported measure of health status at the time of ART initiation. It is noteworthy, therefore, that
time preferences remained significantly associated with mortality even after controlling for this
health measure.
Our findings show that even simple measures of time preferences can predict mortality
among HIV-infected adults receiving ART. Further analysis of ways in which patients’ time
preferences predict clinical outcomes may provide valuable guidance for programs that provide
care to growing numbers of patients and seek to increase the efficiency with which they provide
treatment support. Implementing simple measures of time preferences among larger cohorts of
adults receiving ART and assessing their association with key treatment outcomes is an impor-
tant next step for research in this area. Time preference measures may also be useful for pre-
dicting HIV risk behaviors.
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